BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20817429)

  • 1. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation.
    Fu Y; Zhao H; Zhang T; Chi F
    Auris Nasus Larynx; 2011 Apr; 38(2):165-71. PubMed ID: 20817429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
    Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
    Gouveris H; Selivanova O; Mann W
    Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc in the treatment of idiopathic sudden sensorineural hearing loss.
    Yang CH; Ko MT; Peng JP; Hwang CF
    Laryngoscope; 2011 Mar; 121(3):617-21. PubMed ID: 20928835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of intratympanic dexamethasone injection as salvage treatment in idiopathic sudden hearing loss.
    Lee HS; Kim JM; Kim YJ; Chung DH; Seo BS; Kim SH
    J Otolaryngol Head Neck Surg; 2008 Apr; 37(2):263-8. PubMed ID: 19128624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?
    Ahn JH; Yoo MH; Yoon TH; Chung JW
    Laryngoscope; 2008 Feb; 118(2):279-82. PubMed ID: 17989574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness.
    Ahn JH; Han MW; Kim JH; Chung JW; Yoon TH
    Acta Otolaryngol; 2008 Feb; 128(2):128-31. PubMed ID: 17851916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
    Herr BD; Marzo SJ
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):527-31. PubMed ID: 15806039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of sensorineural hearing loss in acute viral otitis media with intratympanic dexamethasone and hyaluronic acid in comparison with intravenous therapy].
    Stenner M; Jecker P; Gouveris H; Mann W
    Laryngorhinootologie; 2006 Jan; 85(1):32-7. PubMed ID: 16444653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss.
    Cvorovic L; Jovanovic MB; Milutinovic Z; Arsovic N; Djeric D
    Otol Neurotol; 2013 Aug; 34(6):1021-6. PubMed ID: 23820795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic dexamethasone for refractory sudden sensorineural hearing loss.
    Hunchaisri N; Chantapant S; Srinangyam N
    J Med Assoc Thai; 2010 Dec; 93(12):1406-14. PubMed ID: 21344803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss.
    Choung YH; Park K; Shin YR; Cho MJ
    Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
    Suzuki H; Fujimura T; Ikeda K; Shiomori T; Udaka T; Ohbuchi T; Nagatani G
    Acta Otolaryngol; 2008 Jan; 128(1):61-5. PubMed ID: 17851957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
    Battaglia A; Burchette R; Cueva R
    Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy (intratympanic dexamethasone + high-dose prednisone taper) for idiopathic sudden sensorineural hearing loss.
    Rauch SD; Reda DJ
    Otol Neurotol; 2009 Feb; 30(2):254-5; author reply 255-6. PubMed ID: 18849885
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.